Abingdon Health announces £1M Innovate UK funding for the development of a fully quantitative lateral flow Smartphone Reader Innovate UK has released £1M...
Concepta PLC to use Abingdon Health‘s lateral flow m-Health technology in the fertility tracking and pregnancy testing market
The importance of processing data from lateral flow rapid tests while recording the exact GPS position
Abingdon Health and DCN Diagnostics have announced a commercial partnership to provide Abingdon Health’s proprietary AppDx® Smartphone m-Health technology to DCN Diagnostics’ customer...
mHealth Software Regulation: part II: Regulations for mHealth in the USA, the largest diagnostic market.
mHealth Software Regulation: part I: European regulation surrounding the rapid growing mHealth market.
“Early adopters such as triathletes are at the pointy end of this drive towards consumer health diagnostics.”
What barriers can be broken down to aid recruitment and retention of clinical trial volunteers?
See how rapid near-patient tests and data solutions can facilitate a patient centric approach to clinical trials.
Patient-experience and clinician-needs should be at the heart of monitoring drug therapy. Is there a device that aid these patient and clinician needs?
The use of near-patient test and mHealth technology for aiding therapeutic differentiation.